The North America cardiovascular devices market is expected to reach US$ 30,779.03 million by 2028 from US$ 19,680.36 million in 2021. The market is estimated to grow at a CAGR of 6.6% from 2021 to 2028.

In the last decade, the world witnessed notable developments in cardiovascular devices, aiding physicians and patients with new approaches to managing atrial arrhythmias, ventricular arrhythmias, and ventricular atrial fibrillation, among other medical conditions. The growing prevalence of arrhythmia and other cardiovascular diseases (CVDs) is encouraging the introduction of improved cardiovascular devices. According to the World Health Organization (WHO), ~30 million people experience a stroke each year. The American Heart Association states that ~50% of all adults in the US have a type of cardiovascular diseases. Furthermore, more than 130 million people, i.e., 45.1%, of the US population are projected to have a type of cardiovascular diseases by 2035. As per the American Heart Association (AHA) 2019 statistics, 121.5 million adults in the US, i.e., around half of the US adult population, suffer from a cardiovascular diseases. The North America cardiovascular devices market is expected to grow at a good CAGR during the forecast period.

North America Cardiovascular Devices Revenue and Forecast to 2028 (US$ Million)

North America Cardiovascular Devices Market Segmentation

The North America cardiovascular devices market is segmented into device, application, end user, and country. Based on device, the market is segmented into electrocardiography (ECG), pacemaker, stent, defibrillator, cardiac catheter, guidewire, heart valve, event monitor, and others. The event monitor segment dominated the North America cardiovascular devices market in 2020. Based on application, the market is segmented into coronary heart disease, sudden cardiac arrest, stroke, cerebrovascular heart disease, and others. The coronary heart disease segment dominated the market in 2020. Based on end-user, the market is segmented into hospitals, ambulatory surgery centers, and cardiac centers. The hospitals segment dominated the market in 2020. Based on country, the North America cardiovascular devices market is segmented into the US, Mexico, and Canada. The US dominated the North America cardiovascular devices market in 2020.

Medtronic, Boston Scientific Corporation, Abbott, Johnson and Johnson Service Inc, General Electric Company, Koninklijke Philips N.V, Siemens Healthineers AG, BD, B. Braun Melsungen AG, and Edwards Lifesciences Corporation are among the leading companies in the North America cardiovascular devices market.

TABLE OF CONTENTS

1. Introduction
1.1 Study Scope
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 North America Cardiovascular Devices Market – By Device
1.3.2 North America Cardiovascular Devices Market – By Application
1.3.3 North America Cardiovascular Devices Market – By End User
1.3.4 North America Cardiovascular Devices Market – By Country
2. Key Takeaways
2.1 Overview
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. North America Cardiovascular Devices Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America PEST Analysis
4.3 Experts Opinion
5. North America Cardiovascular Devices Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Increasing Prevalence of Cardiovascular Diseases
5.1.2 Rising Number of Product Launches and Approvals
5.2 Key Market Restraints
5.2.1 High Cost of Products and Procedures
5.3 Key Market Opportunities
5.3.1 Untapped Potential of Emerging Economies
5.4 Future Trends
5.4.1 Continuous Technological Advancements
5.5 Impact Analysis
6. Cardiovascular Devices Market– North America Analysis
6.1 North America Cardiovascular Devices Market Revenue Forecast and Analysis
7. North America Cardiovascular Devices Market Analysis – By Device
7.1 Overview
7.2 Cardiovascular Devices Market Revenue Share, by Device (2021 & 2028)
7.3 Electrocardiography (ECG) Market
7.3.1 Overview
7.3.2 Electrocardiography (ECG) Market Revenue and Forecast to 2028 (US$ Mn)
7.4 Pacemaker Market
7.4.1 Overview
7.4.2 Pacemaker Market Revenue and Forecast to 2028 (US$ Mn)
7.5 Stent Market
7.5.1 Overview
7.5.2 Stent Market – Revenue and Forecast to 2028 (US$ Million)
7.6 Defibrillator Market
7.6.1 Overview
7.6.2 Defibrillator Market – Revenue and Forecast to 2028 (US$ Million)
7.7 Cardiac Catheter Market
7.7.1 Overview
7.7.2 Cardiac Catheter Market Revenue and Forecast to 2028 (US$ Mn)
7.8 Guidewire Market
7.8.1 Overview
7.8.2 Guidewire Market Revenue and Forecast to 2028 (US$ Mn)
7.9 Heart Valve Market
7.9.1 Overview
7.9.2 Heart Valve Market Revenue and Forecast to 2028 (US$ Mn)
7.10 Event Monitor Market
7.10.1 Overview
7.10.2 Event Monitor Market Revenue and Forecast to 2028 (US$ Mn)
7.11 Other Devices Market
7.11.1 Overview
7.11.2 Other Devices Market Revenue and Forecast to 2028 (US$ Mn)
8. North America Cardiovascular Devices Market-Analysis and Forecasts To 2028 – Application
8.1 Overview
8.2 North America Cardiovascular Devices Market Share by Application 2021 & 2028 (%)
8.3 Coronary Heart Disease Market
8.3.1 Overview
8.3.2 Coronary Heart Disease Market Revenue and Forecast to 2028 (US$ Mn)
8.4 Sudden Cardiac Arrest market
8.4.1 Overview
8.4.2 Sudden Cardiac Arrest Market Revenue and Forecast to 2028 (US$ Mn)
8.5 Stroke Market
8.5.1 Overview
8.5.2 Stroke Market Revenue and Forecast to 2028 (US$ Mn)
8.6 Cerebrovascular Heart Disease Market
8.6.1 Overview
8.6.2 Cerebrovascular Heart Disease Market Revenue and Forecast to 2028 (US$ Mn)
8.7 Others Market
8.7.1 Overview
8.7.2 Others Market Revenue and Forecast to 2028 (US$ Mn)
9. North America Cardiovascular Devices Market-Analysis and Forecasts To 2028 – End User
9.1 Overview
9.2 North America Cardiovascular Devices Market Share by End User 2021 & 2028 (%)
9.3 Hospitals Market
9.3.1 Overview
9.3.2 Hospitals Market Revenue and Forecast to 2028 (US$ Mn)
9.4 Ambulatory Surgery Centers market
9.4.1 Overview
9.4.2 Ambulatory Surgery Centers Market Revenue and Forecast to 2028 (US$ Mn)
9.5 Cardiac Centers Market
9.5.1 Overview
9.5.2 Cardiac Centres Market Revenue and Forecast to 2028 (US$ Mn)
10. North America Cardiovascular Devices Market – Country Analysis
10.1 North America: Cardiovascular Devices Market
10.1.1 Overview
10.1.2 North America: Cardiovascular Devices Market, by Country, 2021 & 2028 (%)
10.1.2.1 US: Cardiovascular Devices Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.1.1 Overview
10.1.2.1.2 US: Cardiovascular Devices Market Revenue and Forecasts to 2028 (US$ Million)
10.1.2.1.3 US: Cardiovascular Devices Market, by Device, 2019–2028 (USD Million)
10.1.2.1.4 US: Cardiovascular Devices Market, by Application, 2019–2028 (USD Million)
10.1.2.1.5 US: Cardiovascular Devices Market, by End User, 2019–2028 (USD Million)
10.1.2.2 Canada: Cardiovascular Devices Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.2.1 Overview
10.1.2.2.2 Canada: Cardiovascular Devices Market Revenue and Forecasts to 2028 (US$ Million)
10.1.2.2.3 Canada: Cardiovascular Devices Market, by Device, 2019–2028 (USD Million)
10.1.2.2.4 Canada: Cardiovascular Devices Market, by Application, 2019–2028 (USD Million)
10.1.2.2.5 Canada: Cardiovascular Devices Market, by End User, 2019–2028 (USD Million)
10.1.2.3 Mexico: Cardiovascular Devices Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.3.1 Overview
10.1.2.3.2 Mexico Cardiovascular Devices Market Revenue and Forecasts to 2028 (US$ Million)
10.1.2.3.3 Mexico: Cardiovascular Devices Market, by Device, 2019–2028 (USD Million)
10.1.2.3.4 Mexico: Cardiovascular Devices Market, by Application, 2019–2028 (USD Million)
10.1.2.3.5 Mexico: Cardiovascular Devices Market, by End User, 2019–2028 (USD Million)
11. Industry Landscape
11.1 Overview
11.2 Inorganic Growth Strategies
11.2.1 Overview
11.3 Organic Growth Strategies
11.3.1 Overview
12. Company Profiles
12.1 Medtronic
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Boston Scientific Corporation
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Abbott
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Johnson and Johnson Services, Inc.
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 General Electric Company
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Koninklijke Philips N.V.
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Siemens Healthineers AG
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 BD
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 B. Braun Melsungen AG
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 Edwards Lifesciences Corporation
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
13. Appendix
13.1 About the Insight Partners
13.2 Glossary of Terms

LIST OF TABLES

Table 1.             Recent Launches/Approvals of Cardiovascular Devices
Table 2.             US: Cardiovascular Devices Market, by Device, 2019–2028 (USD Million)
Table 3.             US: Cardiovascular Devices Market, by Application, 2019–2028 (USD Million)
Table 4.             US: Cardiovascular Devices Market, by End User, 2019–2028 (USD Million)
Table 5.             Canada: Cardiovascular Devices Market, by Device, 2019–2028 (USD Million)
Table 6.             Canada: Cardiovascular Devices Market, by Application, 2019–2028 (USD Million)
Table 7.             Canada: Cardiovascular Devices Market, by End User, 2019–2028 (USD Million)
Table 8.             Mexico: Cardiovascular Devices Market, by Device, 2019–2028 (USD Million)
Table 9.             Mexico: Cardiovascular Devices Market, by Application, 2019–2028 (USD Million)
Table 10.          Mexico: Cardiovascular Devices Market, by End User, 2019–2028 (USD Million)
Table 11.          Recent Inorganic Growth Strategies
Table 12.          Recent Organic Growth Strategies in the Cardiovascular Devices Market
Table 13.          Glossary of Terms
 

● Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the North America Cardiovascular Devices market forecast.
● Highlights key business priorities in order to assist companies to realign their business strategies
● The key findings and recommendations highlight crucial progressive industry trends in North America Cardiovascular Devices market forecast, thereby allowing players across the value chain to develop effective long-term strategies
● Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
● Scrutinize in-depth North America market trends and outlook coupled with the factors driving the Cardiovascular Devices market, as well as those hindering it.
● Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.

The List of Companies – North America Cardiovascular Devices Market

● Medtronic.
● Boston Scientific Corporation.
● Abbott.
● Jhonson and Jhonson Service Inc.
● General Electric Company.
● Koninlijke Philips N.V.
● Siemens Healthineers AG.
● BD.
● B.Bruna melsungen AG.
● Edwards Lifesciences Corporation.